AstraZeneca PLC (AZN)
75.01
+3.81
(+5.35%)
USD |
NASDAQ |
Apr 25, 16:00
75.01
0.00 (0.00%)
After-Hours: 17:17
AstraZeneca Market Cap: 232.56B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 220.75B |
| April 23, 2024 | 219.66B |
| April 22, 2024 | 217.43B |
| April 19, 2024 | 212.53B |
| April 18, 2024 | 211.94B |
| April 17, 2024 | 212.47B |
| April 16, 2024 | 211.65B |
| April 15, 2024 | 213.09B |
| April 12, 2024 | 213.71B |
| April 11, 2024 | 215.32B |
| April 10, 2024 | 211.17B |
| April 09, 2024 | 212.10B |
| April 08, 2024 | 209.90B |
| April 05, 2024 | 209.12B |
| April 04, 2024 | 208.78B |
| April 03, 2024 | 207.14B |
| April 02, 2024 | 207.73B |
| April 01, 2024 | 208.50B |
| March 28, 2024 | 210.05B |
| March 27, 2024 | 211.63B |
| March 26, 2024 | 205.65B |
| March 25, 2024 | 204.19B |
| March 22, 2024 | 205.43B |
| March 21, 2024 | 205.21B |
| March 20, 2024 | 203.79B |
| Date | Value |
|---|---|
| March 19, 2024 | 204.19B |
| March 18, 2024 | 204.16B |
| March 15, 2024 | 205.59B |
| March 14, 2024 | 207.85B |
| March 13, 2024 | 209.52B |
| March 12, 2024 | 208.97B |
| March 11, 2024 | 209.80B |
| March 08, 2024 | 206.18B |
| March 07, 2024 | 205.21B |
| March 06, 2024 | 202.36B |
| March 05, 2024 | 200.94B |
| March 04, 2024 | 200.87B |
| March 01, 2024 | 200.28B |
| February 29, 2024 | 198.92B |
| February 28, 2024 | 202.61B |
| February 27, 2024 | 205.65B |
| February 26, 2024 | 204.41B |
| February 23, 2024 | 204.10B |
| February 22, 2024 | 198.83B |
| February 21, 2024 | 201.80B |
| February 20, 2024 | 201.65B |
| February 16, 2024 | 199.26B |
| February 15, 2024 | 194.83B |
| February 14, 2024 | 191.17B |
| February 13, 2024 | 189.22B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
97.80B
Minimum
May 13 2019
234.99B
Maximum
Apr 24 2023
168.97B
Average
176.65B
Median
Market Cap Benchmarks
| GSK PLC | 83.55B |
| Amgen Inc | 144.47B |
| Sanofi SA | 123.15B |
| Viking Therapeutics Inc | 6.924B |
| Fusion Pharmaceuticals Inc | 1.813B |
Market Cap Related Metrics
| PE Ratio | 39.17 |
| PS Ratio | 5.115 |
| PEG Ratio | 0.4805 |
| Price to Book Value | 5.941 |
| Price to Free Cash Flow | 35.68 |
| Price | 75.01 |
| Earnings Yield | 2.55% |
| PEGY Ratio | 0.4688 |
| Operating PE Ratio | 26.87 |
| Normalized PE Ratio | 36.74 |